Dolutegravir-based ART recommended for all – if reliable contraception is available
Brazil confirms dolutegravir is the most effective drug for first-line HIV treatment
On-demand dosing as effective as daily dosing in first year of French PrEP study
People on effective HIV treatment don’t pass the virus to sexual partners
Zero transmissions mean zero risk – PARTNER 2 study results announced
The “Undetectable = Untransmittable” message goes global: I=I, N=N and B=B
Kenyan women can distribute HIV self-test kits to their sexual partners without a significant risk of intimate partner violence
It’s time to make PrEP available to all who need it
